The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
Abstract
Exercise intolerance is a prominent symptom in patients with mitochondrial myopathy (MM), but it is still unsettled whether exercise training is safe and beneficial for patients with MM. To address this, we studied the effect of 12 weeks cycle training on exercise capacity, quality of life and underlying molecular and cellular events in five patients with single large-scale deletions, one with a microdeletion and 14 with point mutations of mitochondrial DNA (mtDNA), and 13 healthy subjects. Each training session lasted 30 min, and was performed at an intensity of 70% of VO2max (maximal oxygen uptake). Each subject performed 50 training sessions in 12 weeks. All subjects were evaluated before and after training, and 13 MM patients were studied after 8 weeks of deconditioning. Evaluation included VO2max and mutation load and mtDNA quantity, mitochondrial enzymatic activity, and number of centrally nucleated, apoptotic, ragged red and cytochrome oxidase (COX)-negative fibres in muscle biopsies from the quadriceps muscle. After 12 weeks of training, VO2max and muscle citrate synthase increased in MM (26 and 67%) and healthy (17 and 65%) subjects, while mtDNA quantity in muscle only increased in the MM patients (81%). In the MM patients, training did not change mtDNA mutation load in muscle, mitochondrial enzyme complex activities, muscle morphology and plasma creatine kinase. After deconditioning, VO2max and citrate synthase activity returned to values before training, while muscle mtDNA mutation load decreased. These findings show that aerobic training efficiently improves oxidative capacity in MM patients. Based on unchanged levels of mutant load in muscle, morphological findings on muscle biopsy and plasma creatine kinase levels during training, the treatment appears to be safe. Regular, supervised aerobic exercise is therefore recommended in MM patients with the studied mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various types of exercise training verifiably improve mitochondrial oxidative function in aging and mitochondrial myopathic muscles (Irving et al., 2015; Jeppesen et al., 2006; Short et al., 2004; Short et al., 2003; Wenz et al., 2009).”
From Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases (2017) · cites this paper as Jeppesen et al., 2006
In the citing paper
“Well tolerated and safe, endurance training for up to 14 weeks has been found to improve OXPHOS function, although no concomitant shift in mutated mtDNA levels in muscle has been observed and cessation in training does cause a loss of the physiological adaptations [228][229][230].”
From Mitochondrial DNA mutations and human disease (2010) · cites this paper as [229]
Citations
Cites
Paternal Inheritance of Mitochondrial DNA
Schwartz, M., & Vissing, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020350 · Cited by 695
Experimental human muscle damage: morphological changes in relation to other indices of damage.
Jones, D. A., Newham, D. J., Round, J. M., & Tolfree, S. E. (1986) · The Journal of Physiology · doi:10.1113/jphysiol.1986.sp016126 · Cited by 476
The ultrastructure of the normal human skeletal muscle
Hoppeler, H. H., L�thi, P., Claassen, H., Weibel, E. R., & HOWALD, H. (1973) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00588462 · Cited by 444
Progressive Increase of the Mutated Mitochondrial DNA Fraction in Kearns-Sayre Syndrome
Larsson, N.-G., Holme, E., Kristiansson, B., Oldfors, A., & Tulinius, M. (1990) · Pediatric Research · doi:10.1203/00006450-199008000-00011 · Cited by 324
Significance of skeletal muscle oxidative enzyme enhancement with endurance training.
Gollnick, P. D., & Saltin, B. (1982) · Clinical Physiology · doi:10.1111/j.1475-097x.1982.tb00001.x · Cited by 277
Is peak quadriceps blood flow in humans even higher during exercise with hypoxemia?
Rowell, L. B., Saltin, B., Kiens, B., & Christensen, N. J. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.251.5.h1038 · Cited by 242
Taivassalo, T., Shoubridge, E. A., Chen, J. M., Kennaway, N. G., DiMauro, S., Arnold, D. L., & Haller, R. G. (2001) · Annals of Neurology · doi:10.1002/ana.1050 · Cited by 213
Relaxed Replication of mtDNA: A Model with Implications for the Expression of Disease
Chinnery, P. F., & Samuels, D. C. (1999) · The American Journal of Human Genetics · doi:10.1086/302311 · Cited by 200
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle.
Weber, K., Wilson, J., Taylor, L., Brierley, E. J., Johnson, M. A., Turnbull, D. M., & Bindoff, L. A. (1997) · PubMed · Cited by 199
Fischer, C. P., Plomgaard, P., Hansen, A. K., Pilegaard, H., Saltin, B., & Pedersen, B. K. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00206.2004 · Cited by 165
Cited by
Sorted by citations
Mitochondrial Energetics and Therapeutics
Wallace, D. C., Fan, W., & Procaccio, V. (2010) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092314 · Cited by 747
Mitochondrial DNA mutations and human disease
Tuppen, H. A. L., Blakely, E. L., Turnbull, D. M., & Taylor, R. W. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.09.005 · Cited by 676
Parikh, S., Goldstein, A., Koenig, M. K., Scaglia, F., Enns, G. M., Saneto, R., Anselm, I., Cohen, B. H., Falk, M. J., Greene, C., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.177 · Cited by 607
Treatment for mitochondrial disorders
Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D. R., & Chinnery, P. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004426.pub3 · Cited by 501
Mitochondrial Diseases: Hope for the Future
Russell, O. M., Gorman, G. S., Lightowlers, R. N., & Turnbull, D. M. (2020) · Cell · doi:10.1016/j.cell.2020.02.051 · Cited by 480
A modern approach to the treatment of mitochondrial disease
The Mitochondrial Medicine Society, Parikh, S., Saneto, R. P., Falk, M. J., Anselm, I. A., Cohen, B. H., & Haas, R. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0046-0 · Cited by 349
Strength training and aerobic exercise training for muscle disease
Voet, N. B. M., van der Kooi, E. L., Riphagen, I. I., Lindeman, E., van Engelen, B. G. M., & Geurts, A. C. H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003907.pub4 · Cited by 344
A neurological perspective on mitochondrial disease
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70116-2 · Cited by 315
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
Wen, H., Deng, H., Li, B., Chen, J., Zhu, J., Zhang, X., Yoshida, S., & Zhou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02044-3 · Cited by 284
Skeletal muscle mitochondria: A major player in exercise, health and disease
Russell, A. P., Foletta, V. C., Snow, R. J., & Wadley, G. D. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.016 · Cited by 233
DeBalsi, K. L., Hoff, K. E., & Copeland, W. C. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.006 · Cited by 180
Resistance training in patients with single, large-scale deletions of mitochondrial DNA
Murphy, J. L., Blakely, E. L., Schaefer, A. M., He, L., Wyrick, P. S., Haller, R. G., Taylor, R. W., Turnbull, D. M., & Taivassalo, T. (2008) · Brain · doi:10.1093/brain/awn252 · Cited by 164
New treatments for mitochondrial disease—no time to drop our standards
Pfeffer, G., Horváth, R., Klopstock, T., Mootha, V. K., Suomalainen, A., Koene, S., Hirano, M., Zeviani, M., Bindoff, L. A., Yu‐Wai‐Man, P., et al. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.129 · Cited by 166
Morris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Diagnosis and treatment of mitochondrial myopathies
Pfeffer, G., & Chinnery, P. F. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.605389 · Cited by 163
Diagnosis and Treatment of Mitochondrial Myopathies
Ahmed, S. T., Craven, L., Russell, O. M., Turnbull, D. M., & Vincent, A. E. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-00674-4 · Cited by 160
A randomized trial of coenzyme Q 10 in mitochondrial disorders
Glover, E. I., Martin, J. C., Maher, A. C., Thornhill, R. E., Moran, G. R., & Tarnopolsky, M. A. (2010) · Muscle & Nerve · doi:10.1002/mus.21758 · Cited by 137
Strength training and aerobic exercise training for muscle disease
Voet, N. B. M., van der Kooi, E. L., van Engelen, B. G. M., & Geurts, A. C. H. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003907.pub5 · Cited by 130
Ringholm, S., Biensø, R. S., Kiilerich, K., Guadalupe‐Grau, A., Aachmann‐Andersen, N. J., Saltin, B., Plomgaard, P., Lundby, C., Wojtaszewski, J. F. P., Calbet, J. A. L., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00230.2011 · Cited by 136
PGC-1α is Dispensable for Exercise-Induced Mitochondrial Biogenesis in Skeletal Muscle
Rowe, G. C., El‐Khoury, R., Patten, I. S., Rustin, P., & Arany, Z. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041817 · Cited by 132
Kerr, D. S. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.11.005 · Cited by 121
Geto, Z., Molla, M. D., Challa, F., Belay, Y., & Getahun, T. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s232009 · Cited by 116
Emerging concepts in the therapy of mitochondrial disease
Viscomi, C. F., Bottani, E., & Zeviani, M. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.03.001 · Cited by 109
Vigelsø, A., Andersen, N. B., & Dela, F. (2014) · Europe PMC (PubMed Central) · Cited by 96
ATP Citrate Lyase Improves Mitochondrial Function in Skeletal Muscle
Das, S., Morvan, F., Jourde, B., Meier, V., Kahle, P., Brebbia, P., Toussaint, G., Glass, D. J., & Fornaro, M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.006 · Cited by 91
Mitochondrial disorders: Challenges in diagnosis & treatment
Kumarasamy Thangaraj, K., Khan, N., Govindaraj, P., & Meena, A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.154489 · Cited by 88
Pathophysiology of protein aggregation and extended phenotyping in filaminopathy
Kley, R. A., Oflazer, P., Leber, Y., Odgerel, Z., van der Ven, P. F. M., Olivé, M., Ferrer, I., Onipe, A., Mihaylov, M., Bilbao, J. M., et al. (2012) · Brain · doi:10.1093/brain/aws200 · Cited by 86
Current and Emerging Clinical Treatment in Mitochondrial Disease
Tinker, R. J., Lim, A. Z., Stefanetti, R. J., & McFarland, R. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00510-6 · Cited by 83
Bottani, E., Lamperti, C., Prigione, A., Tiranti, V., Persico, N., & Brunetti, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111083 · Cited by 89
Mitochondrial medicine: entering the era of treatment
Koene, S., & Smeitink, J. A. M. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02058.x · Cited by 82
Endurance exercise is protective for mice with mitochondrial myopathy
Wenz, T., Diaz, F., Hernandez, D., & Moraes, C. T. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91571.2008 · Cited by 78
RetractedRadak, Z. O., Kumagai, S., Nakamoto, H., & Goto, S. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01051.2006 · Cited by 72
Davis, R. L., Liang, C., & Sue, C. M. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00010-5 · Cited by 77
Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome
Smits, B. W., van den Heuvel, L., Knoop, H., Küsters, B., Janssen, A. J. M., Borm, G. F., Bleijenberg, G., Rodenburg, R. J., & van Engelen, B. G. M. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.005 · Cited by 69
Exercise in neuromuscular disease
Anziska, Y., & Sternberg, A. (2013) · Muscle & Nerve · doi:10.1002/mus.23771 · Cited by 68
Community exercise is feasible for neuromuscular diseases and can improve aerobic capacity
Wallace, A., Pietrusz, A., Dewar, E. L., Dudziec, M., Jones, K. L., Hennis, P. J., Sterr, A., Baio, G., Machado, P., Laurá, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007265 · Cited by 67
Grady, J. P., Murphy, J. L., Blakely, E. L., Haller, R. G., Taylor, R. W., Turnbull, D. M., & Tuppen, H. A. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114462 · Cited by 64
Mitochondrial diseases in childhood: a clinical approach to investigation and management
Kisler, J., Whittaker, R. G., & McFarland, R. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2009.03605.x · Cited by 63
Exercise in Neuromuscular Diseases
Abresch, R. T., Carter, G. T., Han, J. J., & McDonald, C. M. (2012) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2012.06.001 · Cited by 65
Resistance training in patients with limb‐girdle and becker muscular dystrophies
Sveen, M., Andersen, S., Ingelsrud, L. H., Blichter, S., Olsen, N. E., Jønck, S., Krag, T. O. B., & Vissing, J. (2012) · Muscle & Nerve · doi:10.1002/mus.23491 · Cited by 62
Monitoring clinical progression with mitochondrial disease biomarkers
Steele, H. E., Horváth, R., Lyon, J. J., & Chinnery, P. F. (2017) · Brain · doi:10.1093/brain/awx168 · Cited by 63
Yang/Qi Invigoration: An Herbal Therapy for Chronic Fatigue Syndrome with Yang Deficiency?
Leong, P. K., Wong, H. S., Chen, J., & Ko, K. M. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/945901 · Cited by 61
Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy
Madsen, K. L., Buch, A. E., Cohen, B. H., Falk, M. J., Goldsberry, A., Goldstein, A. C., Karaa, A., Koenig, M. K., Muraresku, C. C., Meyer, C. J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000008861 · Cited by 63
Higashimoto, T., Baldwin, E. E., Gold, J. I., & Boles, R. G. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2007.123661 · Cited by 60
Montes, J., Garber, C. E., Kramer, S. S., Montgomery, M. J., Young, S. D., Kamil‐Rosenberg, S., Carr, B. M., Cruz, R. E., Strauss, N. E., Sproule, D. M., et al. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150101 · Cited by 60
Neurotoxic effects of androgens in spinal and bulbar muscular atrophy
Parodi, S., & Pennuto, M. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.06.003 · Cited by 59
Porcelli, S., Marzorati, M., Morandi, L. O., & Grassi, B. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00885.2015 · Cited by 57
Habitual Physical Activity in Mitochondrial Disease
Apabhai, S., Gorman, G. S., Sutton, L., Elson, J. L., Plötz, T., Turnbull, D. M., & Trenell, M. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022294 · Cited by 55
Rehabilitation Management of Neuromuscular Disease: The Role of Exercise Training
Abresch, R. T., Han, J. J., & Carter, G. T. (2009) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e3181a8d36b · Cited by 55
Mancuso, M., Angelini, C. I., Bertini, E., Carelli, V., Comi, G. P., Minetti, C., Moggio, M. G., Mongini, T., Servidei, S., Tonin, P., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.10.012 · Cited by 52
Bates, M. G. D., Newman, J. H., Jakovljević, D. G., Hollingsworth, K. G., Alston, C. L., Zalewski, P., Klawe, J. J., Blamire, A. M., MacGowan, G. A., Keavney, B. D., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.05.062 · Cited by 52
Fan, H., Lee, H.-F., Yue, C.-T., & Chi, C. (2021) · Life · doi:10.3390/life11111111 · Cited by 51
Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)
Preisler, N. R., Andersen, G., Thøgersen, F. B., Crone, C. G., Jeppesen, T. D., Wibrand, F., & Vissing, J. (2009) · Neurology · doi:10.1212/01.wnl.0000341274.61236.02 · Cited by 51
Advances in primary mitochondrial myopathies
de Barcelos, I. P., Emmanuele, V., & Hirano, M. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000743 · Cited by 48
Parikh, S., Goldstein, A. C., Koenig, M. K., Scaglia, F., Enns, G. M., Saneto, R. P., Anselm, I. A., Collins, A. R., Cohen, B. H., DeBrosse, S. D., et al. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.09.003 · Cited by 47
Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets
Zegallai, H. M., & Hatch, G. M. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-04021-0 · Cited by 53
PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism
Coppi, L., Ligorio, S., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136913 · Cited by 49
Short- and long-term effects of endurance training in patients with mitochondrial myopathy
Jeppesen, T. D., Dunø, M., Schwartz, M., Krag, T., Rafiq, J., Wibrand, F., & Vissing, J. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02660.x · Cited by 46
Exercise as a Therapeutic Strategy for Primary Mitochondrial Cytopathies
Tarnopolsky, M. A. (2014) · Journal of Child Neurology · doi:10.1177/0883073814538512 · Cited by 45
Mitochondrial myopathies: developments in treatment
Hassani, A., Horváth, R., & Chinnery, P. F. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833d1096 · Cited by 44
Biomarkers for Detecting Mitochondrial Disorders
Finsterer, J., & Zarrouk‐Mahjoub, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020016 · Cited by 42
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies
Siciliano, G., Simoncini, C., Gerfo, A. L., Orsucci, D., Ricci, G., & Mancuso, M. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.10.005 · Cited by 42
Strength training and aerobic exercise training for muscle disease
Voet, N. B. M., van der Kooi, E. L., Riphagen, I. I., Lindeman, E., van Engelen, B. G. M., & Geurts, A. C. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003907.pub3 · Cited by 40
Menezes, M. J., Riley, L. G., & Christodoulou, J. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.025 · Cited by 40
Fritzen, A. M., Thøgersen, F. B., Thybo, K., Vissing, C. R., Krag, T. O. B., Ruiz‐Ruiz, C., Risom, L., Wibrand, F., Høeg, L. D., Kiens, B., et al. (2019) · Cells · doi:10.3390/cells8030237 · Cited by 37
Exercise-induced mitochondrial dysfunction: a myth or reality?
Ostojić, S. M. (2016) · Clinical Science · doi:10.1042/cs20160200 · Cited by 37
How Can We Treat Mitochondrial Encephalomyopathies? Approaches to Therapy
Horváth, R., Gorman, G. S., & Chinnery, P. F. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.07.002 · Cited by 36
EFFECTS OF AEROBIC EXERCISE ON THE CIRCADIAN RHYTHM OF HEART RATE AND BLOOD PRESSURE
Shiotani, H., Umegaki, Y., Tanaka, M., Kimura, M., & Ando, H. (2009) · Chronobiology International · doi:10.3109/07420520903553443 · Cited by 35
Therapeutic Strategies for Mitochondrial Disorders
Finsterer, J., & Bindu, P. S. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.06.023 · Cited by 35
Clinical syndromes associated with mtDNA mutations: where we stand after 30 years
Carelli, V., & Morgia, C. L. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170097 · Cited by 34
Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy
Venhoff, N., Lebrecht, D., Pfeifer, D., Venhoff, A. C., Bissé, E., Kirschner, J., & Walker, U. A. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4076 · Cited by 33
Fritzen, A. M., Andersen, S., Qadri, K. A. N., Thøgersen, F. B., Krag, T. O. B., Ørngreen, M. C., Vissing, J., & Jeppesen, T. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103113 · Cited by 35
Gordon, B. S., Steiner, J. L., Rossetti, M. L., Qiao, S., Ellisen, L. W., Govindarajan, S. S., Eroshkin, A. M., Williamson, D. L., & Coen, P. M. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2017 · Cited by 33
Increased capillaries in mitochondrial myopathy: implications for the regulation of oxygen delivery
Taivassalo, T., Ayyad, K., & Haller, R. G. (2012) · Brain · doi:10.1093/brain/awr293 · Cited by 31
Lactate metabolism during exercise in patients with mitochondrial myopathy
Jeppesen, T. D., Ørngreen, M. C., van Hall, G., & Vissing, J. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.05.007 · Cited by 31
Management of Leigh syndrome: Current status and new insights
Chen, L., Cui, Y., Jiang, D., Ma, C. Y., Tse, H., Hwu, W., & Lian, Q. (2017) · Clinical Genetics · doi:10.1111/cge.13139 · Cited by 32
Perspectives of mitochondrial medicine
Zorov, D. B., Исаев, Н. К., Plotnikov, E. Y., Silachev, D. N., Zorova, L. D., Pevzner, I. B., Morosanova, M. A., Jankauskas, S. S., Zorov, S. D., & Babenko, V. А. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913090034 · Cited by 28
Experimental Strategies Towards Treating Mitochondrial DNA Disorders
Gardner, J. L., Craven, L., Turnbull, D. M., & Taylor, R. W. (2007) · Bioscience Reports · doi:10.1007/s10540-007-9042-3 · Cited by 28
Exercise is muscle mitochondrial medicine
Oliveira, A. N., Richards, B. J., Slavin, M., & Hood, D. A. (2021) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000250 · Cited by 26
Hou, Y., Xie, Z., Zhao, X., Yuan, Y., Dou, P., & Wang, Z. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219628 · Cited by 27
Metabolic Myopathies in the Era of Next-Generation Sequencing
Urtizberea, J. A., Severa, G., & Malfatti, E. (2023) · Genes · doi:10.3390/genes14050954 · Cited by 27
Fatigue in primary genetic mitochondrial disease: No rest for the weary
Parikh, S., Galioto, R., Lapin, B. R., Haas, R., Hirano, M., Koenig, M. K., Saneto, R. P., Zolkipli‐Cunningham, Z., Goldstein, A. C., & Karaa, A. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.09.012 · Cited by 27
Khaghani, F., Hemmati, M., Ebrahimi, M., & Salmaninejad, A. (2024) · Current Genomics · doi:10.2174/0113892029308327240612110334 · Cited by 28
Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy
Gimenes, A. C., Bravo, D. M., Nápolis, L. M., de Mello, M. T., Oliveira, A. S. B., Neder, J. A., & Nery, L. E. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143467 · Cited by 26
Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?
Ben‐Shachar, D., & Ene, H. M. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.007 · Cited by 27
Exercise therapy for muscle and lower motor neuron diseases.
Sheikh, A. M., & Vissing, J. (2019) · Europe PMC (PubMed Central) · Cited by 26
A Novel In Vitro Model for Studying Quiescence and Activation of Primary Isolated Human Myoblasts
Sellathurai, J., Cheedipudi, S. M., Dhawan, J., & Schrøder, H. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064067 · Cited by 27
Nutrition and exercise in Pompe disease
Tarnopolsky, M. A., & Nilsson, M. I. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.05.52 · Cited by 23
Endurance Exercise Training in Young Adults with Barth Syndrome: A Pilot Study
Cade, W. T., Reeds, D. N., Peterson, L. R., Bohnert, K. L., Tinius, R. A., Benni, P. B., Byrne, B. J., & Taylor, C. L. (2016) · JIMD Reports · doi:10.1007/8904_2016_553 · Cited by 24
Physical Exercise and Mitochondrial Disease: Insights From a Mouse Model
Fiuza‐Luces, C., Valenzuela, P. L., Laine-Menéndez, S., la Torre, M. F.-D., Bermejo-Gómez, V., Rufián-Vázquez, L., Arenas, J., Martín, M. A., Lucía, A., & Morán, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00790 · Cited by 25
Cardiovascular Involvement in mtDNA Disease
Lioncino, M., Monda, E., Caiazza, M., Fusco, A., Cirillo, A., Dongiglio, F., Simonelli, V., Sampaolo, S., Ruggiero, L., Scarano, G., et al. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.07.003 · Cited by 23
Mitochondrial mutations alter endurance exercise response and determinants in mice
Schaefer, P. M., Rathi, K. S., Butic, A., Tan, W., Mitchell, K. M., & Wallace, D. C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200549119 · Cited by 23
Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle
Vásquez-Trincado, C., Dunn, J., Han, J. I., Hymms, B., Tamaroff, J. G., Patel, M., Nguyen, S., Dedio, A., Wade, K., Enigwe, C., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155201 · Cited by 23
Chronisch-progressive externe Ophthalmoplegie und Kearns-Sayre-Syndrom
Wabbels, B., Ali, N., Kunz, W. S., Roggenkämper, P., & Kornblum, C. (2008) · Der Ophthalmologe · doi:10.1007/s00347-007-1643-5 · Cited by 23
Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction
Schreuder, L. T. W., der Sanden, M. W. G. N., de Hair, A., Peters, G., Wortmann, S. B., Bok, L. A., & Morava, É. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9085-7 · Cited by 23
Aerobic Exercise Training in Patients With mtDNA-Related Mitochondrial Myopathy
Jeppesen, T. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00349 · Cited by 23
Pathophysiology and Management of Fatigue in Neuromuscular Diseases
Torri, F., Lopriore, P., Montano, V., Siciliano, G., Mancuso, M., & Ricci, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055005 · Cited by 26
Montes, J., Garber, C. E., Kramer, S. S., Montgomery, M. J., Young, S. D., Kamil‐Rosenberg, S., Carr, B. M., Strauss, N. E., Sproule, D. M., & Vivo, D. C. D. (2014) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140004 · Cited by 20
Therapies in inborn errors of oxidative metabolism
Schiff, M., Bénit, P., Jacobs, H. T., Vockley, J., & Rustin, P. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.04.006 · Cited by 21
Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy
van Tienen, F. H. J., Zelissen, R., Timmer, E. D. J., van Gisbergen, M. W., Lindsey, P. J., Quattrocelli, M., Sampaolesi, M., Hartog, E. N. M. M.-D., de Coo, I. F. M., & Smeets, H. J. M. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1510-8 · Cited by 20
Metadata
- Authors
- Jeppesen, T. D., Schwartz, M., Olsen, D. B., Wibrand, F., Krag, T., Duno, M., Hauerslev, S., & Vissing, J.
- Affiliations
- Rigshospitalet (DK)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06-09
- Volume
- 129
- Issue
- 12
- Pages
- 3402-3412
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2111001861
- Cited by
- 211
- References
- 32
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 10 · 2022: 5 · 2021: 14 · 2020: 13 · 2019: 20 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 12 · 2014: 10 · 2013: 13 · 2012: 19
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- Fondation pour la Recherche Médicale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- mitochondrial myopathy, aerobic exercise training, exercise capacity, exercise intolerance, mitochondrial DNA mutations, mitochondrial DNA deletions, VO2max, citrate synthase, mitochondrial enzyme activity, deconditioning, creatine kinase, muscle biopsy, exercise safety, quality of life
- MeSH terms
- Adult, Aerobiosis, Creatine Kinase, DNA, Mitochondrial, Exercise Therapy, Female, Heart Rate, Humans, Lactates, Male, Middle Aged, Mitochondria, Oxygen Consumption, Quality of Life, Treatment Outcome, Mitochondrial Myopathies, Gene Deletion, Point Mutation, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review